Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigs
- 1 January 1993
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 23 (1) , 32-38
- https://doi.org/10.1111/j.1365-2222.1993.tb02481.x
Abstract
We have reported that an intratracheal injection of murine recombinant interleukin‐5 (mrIL‐5, 15 μg/0.0 ml/animal) induces the increased number of inflammatory leucocytes and epithelial cells in bronchoaiveolar lavage fluid (BALF) 24 hr after administration of mrIL‐5 in guinea‐pigs [1]. In this paper, we have examined the effects of mrIL‐5 on bronchial reactivity in guinea‐pigs. An intratracheal injection of mrIL‐5 (15 μg/0.0 ml/animal) induced airway hyperresponsiveness to acetytcholine (ACh) which was accompanied with eosinophilia and neutrophilia in blood at 24 hr in guinea‐pigs. Bovine serum albumin (BSA, 15 μg/0.0 ml/animal) used as a reference material did not cause airway hyperresponsiveness, blood eosinophilia and neutrophilia. Prednisotone (20 mg/kg, i.p.) inhibited mrIL‐5‐induccd airway hyperresponsiveness, eosinophilia and neutrophilia. Ketotifen (2 mg/kg, i.p.) also reduced this airway hyperresponsiveness and neutrophilia but not eosinophilia. In contrast, the injection of 2% disodium cromoglycale (DSCG) into the trachea showed the tendency of inhibitory effects against mrIL‐5‐induced airway hyperresponsiveness, eosinophilia and neutrophilia. The present data indicate that mrIL‐5 induces airway hyperresponsiveness, blood eosinophilia and neutrophilia in guinea‐pigs and that prednisolone and ketotifen inhibit mrIL‐5‐induced airway hyperresponsiveness accompanied with reduction of the increased number of leucocytes, suggesting that eosinophils and neutrophilia in blood may be important for the onset of bronchial hyperresponsiveness caused by mrIL‐5 in guinea‐pigs.Keywords
This publication has 16 references indexed in Scilit:
- Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approachEuropean Journal of Pharmacology, 1992
- Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.Journal of Clinical Investigation, 1991
- Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.The Journal of Experimental Medicine, 1991
- Role of Interleukin-5 in Local Accumulation of Eosinophils in Mouse Allergic PeritonitisInternational Archives of Allergy and Immunology, 1991
- The effects of drugs on Sephadex‐induced eosinophilia and lung hyper‐responsiveness in the ratBritish Journal of Pharmacology, 1990
- Antibody to Interleukin-5 Inhibits Helminth-Induced Eosinophilia in MiceScience, 1989
- New concepts in the pathogenesis of bronchial hyperresponsiveness and asthmaJournal of Allergy and Clinical Immunology, 1989
- Late-phase airway reaction and inflammationJournal of Allergy and Clinical Immunology, 1989
- T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMAThe Lancet, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988